semaglutide bmi 26 Once-weekly versus placebo in patients with alcohol use disorder and comorbid obesity: a randomised, double-blind, placebo-controlled trial Semaglutide for Weight Loss: How

As we weave together these strands of medical innovation, lifestyle modifications, and technological advancements, a clear picture emerges: the future of obesity and cardiometabolic health lies in a holistic approach

Orforglipron, being an oral drug, will benefit Lilly in a few ways

Timothy Garvey 1

Semaglutide, marketed as Ozempic for type 2 diabetes and Wegovy for weight management, has raised questions about its effects on testosterone levels

T.CaesarR.Manners-HolmL.et al

Managing metabolic dysfunction is a growing challenge for healthcare providers, but new advances in GLP-1 therapies and gut health optimization offer promising solutions....